secwatch.observer — SEC 8-K summary
======================================

Issuer:     Co-Diagnostics, Inc. (CODX)
CIK:        0001692415
Form:       8-K
Filed at:   2025-11-13T23:59:59+00:00
Accession:  0001493152-25-022283
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Co-Diagnostics Q3 net loss narrows to $5.9M; announces JV in Saudi Arabia and SPAC exploration for India unit
--------------------------------------------------------------------------------

- Revenue $0.1M, down from $0.6M YoY; net loss $5.9M ($0.16/share) vs $9.7M ($0.32) in Q3 2024.
- Operating loss $7.0M vs $10.2M; adjusted EBITDA loss $6.3M.
- Cash and marketable securities $11.4M at Sept 30, 2025.
- Signed JV with Arabian Eagle Manufacturing for CoMira Diagnostics in KSA and 18 MENA nations.
- Engaged Maxim Group to pursue SPAC transaction for CoSara India JV; closed RDOs totaling ~$10.8M gross.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1692415/000149315225022283/0001493152-25-022283-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1692415/000149315225022283/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-022283

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer